Number of Shares
7,828.28
Current Holdings Value*
$60,650.00
% of Portfolio
1.21%
Total Estimate Gain
$-17.19 Mil
% of Total Estimate Gain
-67.46%

Vantage Consulting Group Inc's FibroGen Inc Holding Summary

As of 2025-03-31, Vantage Consulting Group Inc held 7,828.28 shares of FibroGen Inc(FGEN), totaling $60,650.00. This investment constitutes 1.21% of their stock portfolio, and Vantage Consulting Group Inc now holds 0.19% of the outstanding FibroGen Inc(FGEN) stock.

The initial trade took place in 2020Q4. And since then Vantage Consulting Group Inc has made 1 purchases of FGEN, at an average price of $1,050.86, for a total of 24,250.12 shares. In addition, there have been 3 sales at an average price of $502.06 for 16,421.84 shares. Based on historical transaction data and FGEN's current price of $6.19, Vantage Consulting Group Inc's estimated gain on his FGEN holdings is $-17.19 Mil, reflecting a -67.46% gain to date.

Vantage Consulting Group Inc FGEN ($6.19) Holding Chart

Vantage Consulting Group Inc FGEN ($6.19) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1